Diabetes Diagnostics - Global Strategic Business Report

Report
609 Pages
March 2024
Region: Global
Global Industry Analysts, Inc
ID: 338882

The global market for Diabetes Diagnostics is estimated at US$33.4 Billion in 2023 and is projected to reach US$59.4 Billion by 2030, growing at a CAGR of 7.5% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

Market Growth: Understand the significant growth trajectory of the Test Strips segment, which is expected to reach US$14.7 Billion by 2030 with a CAGR of 7.6%. The Lancets segment is also set to grow at 6.9% CAGR over the next 8 years.
Regional Analysis: Gain insights into the U.S. market, estimated at $12.7 Billion in 2023, and China, forecasted to grow at an impressive 8.8% CAGR to reach $7.6 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

Detailed Market Analysis: Access a thorough analysis of the Global Diabetes Diagnostics Market, covering all major geographic regions and market segments.
Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Diabetes Diagnostics Market.
Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

How is the Global Diabetes Diagnostics Market expected to evolve by 2030?
What are the main drivers and restraints affecting the market?
Which market segments will grow the most over the forecast period?
How will market shares for different regions and segments change by 2030?
Who are the leading players in the market, and what are their prospects?

Report Features:

Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
Company Profiles: Coverage of major players such as Abbott Laboratories, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, and more.
Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 91 Featured):

Abbott Laboratories, Inc.
B. Braun Melsungen AG
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Danaher Corporation
ACON Laboratories, Inc.
ARKRAY, Inc.
A. Menarini Diagnostics Srl
AgaMatrix, Inc.
BIONIME Corporation
Ascensia Diabetes Care Holdings AG
American Laboratory Products Company (ALPCO)
AmbiMedInc
Companion Medical, Inc.
Ciga Healthcare Ltd.

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Diabetes: A Chronic Body Disorder
An Introduction to Diabetes Diagnostics
Diabetes Diagnostics: Easier, Economic, and Efficient Management of the Global Diabetes Epidemic
Developed Regions Lead, Developing Economies to Spearhead Future Growth
Increase in Number of Hospitals & Diagnostics Centers Augurs Well for Market in Developing Regions
Alarming Levels of Diabetes Incidence Worldwide Drives Demand for Diabetes Diagnostic Devices
World Diabetes and Population Statistics (2019, 2030 & 2045)
Global Prevalence of Diabetes: Number of Adults Diagnosed with Diabetes (in Million) by Gender for 2019, 2030 and 2045
World Diabetes Prevalence (2000-2023)
Top 10 Countries with Highest Number of Adults Diagnosed with Diabetes (in Million) for 2019 and 2045
Global Diabetes Mellitus Population Breakdown by Geographic Region: 2019, 2030 and 2045?
Diabetes Emerges as One of the Leading Causes of Mortality
Diabetes-Related Deaths as % of Total Deaths in Below 60 Years Population by Region
Competition
Global Continuous Glucose Monitoring Market Breakdown (in %) by Leading Competitors for 2019
Global Blood Glucose Monitoring Devices Market Share (in %) by Company for 2019
Quality Products at Low Prices: Mantra for Success in the Marketplace
SMBG Makers Turn to Mobile Devices to Woo Users on the Move
World Brands
Recent Market Activity
Diabetes Diagnostics - Global Key Competitors Percentage Market Share in 2023 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2023 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

High Risk of Diabetes in the Fast Expanding Aging Population Benefit Market Expansion
Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
Increasing Healthcare Expenditure Aids Diabetes Diagnostics & Testing Market
World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021, 2023
Increasing Obesity Levels Underpins Market Growth
Average Per Capita Annual Health Expenditure (In US$) due to Obesity
Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
Rising Importance of Real-Time Glucose Sensing and Monitoring Drive Robust Growth in Minimally-Invasive CGM Devices Market
Global Continuous Glucose Monitoring Systems Market by Component for 2023
Global Continuous Glucose Monitoring Systems Market by End-Use (in %) for 2023
CGM Market Breaks through Barriers to Witness Growing Adoption
Growing Role of HbA1c Testing Devices in Monitoring & Management of Diabetes
Rising Popularity of Near Patient Testing Benefits HbA1c Devices Market
Myriad Benefits of POC HbA1c Tests over Lab Tests Drives Widespread Adoption
Glycated Albumin: A Potential Threat to HbA1c
Role of HbA1c Testing in Diabetes Diagnosis and Management
HbA1c Tests for Diabetes Diagnosis Need to Address Issues Related to Hemoglobin Variants
Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis
Despite Competition from CGM Systems and HbA1c Testing Devices, BGM Devices Continues to Witness Demand Growth
Blood Glucose Strips: Low Cost Advantage Augurs Drives Market
Blood Sugar Lancets Market: Sustained Growth in Demand
Self-Monitoring/Household Blood Glucose Sustains Market Growth
Rising Smartphone Penetration Augurs Well for SMBG Market
Smartphone Penetration Rate as Share of Total Population: 2016-2023
Barriers to Adoption of New Technology in BGM Products
Accuracy Issues Plague Blood Glucose Meters Market
Insulin Pens Rise in Popularity for Administering Insulin
Smart Insulin Pens
Increasing Role of Self-Injection Devices in Diabetes Management
Prefilled Syringe Pen Injectors
Human Factors Influence the Design of Self Injection Systems
Pain Free Shots: A Growing R&D Domain
Undiagnosed Diabetes Emerges as a Major Healthcare Challenge, Translates into Untapped Potential for Diabetes Diagnostics Market
Number of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2023
Proportion of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2023
Increased Vulnerability of Diabetics to Various Health Complications Boosts Demand for Diagnostic Devices
Innovations & Product Advancements: Prime Focus Area for Vendors
Focus on Development of Wearable Devices
An Insight into Intriguing Advances in Blood Glucose Monitoring Techniques
Companies Develop Innovative Needle-Free Alternatives
mHealth Solutions for Diabetes Diagnosis
Non-invasive Wearable Glucose Testing Devices
Innovations in Insulin Pumps

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 2: World Historic Review for Diabetes Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 3: World 16-Year Perspective for Diabetes Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
Table 4: World Recent Past, Current & Future Analysis for Test Strips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 5: World Historic Review for Test Strips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 6: World 16-Year Perspective for Test Strips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 7: World Recent Past, Current & Future Analysis for Lancets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 8: World Historic Review for Lancets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 9: World 16-Year Perspective for Lancets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 10: World Recent Past, Current & Future Analysis for Analog Glucose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 11: World Historic Review for Analog Glucose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 12: World 16-Year Perspective for Analog Glucose Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 13: World Recent Past, Current & Future Analysis for Continuous Glucose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 14: World Historic Review for Continuous Glucose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 15: World 16-Year Perspective for Continuous Glucose Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 16: World Recent Past, Current & Future Analysis for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 17: World Historic Review for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 18: World 16-Year Perspective for Syringes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 19: World Recent Past, Current & Future Analysis for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 20: World Historic Review for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 21: World 16-Year Perspective for Pens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 22: World Recent Past, Current & Future Analysis for Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 23: World Historic Review for Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 24: World 16-Year Perspective for Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 25: World Recent Past, Current & Future Analysis for Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 26: World Historic Review for Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 27: World 16-Year Perspective for Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 28: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 29: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 30: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 31: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 32: World Historic Review for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 33: World 16-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 34: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 35: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 36: World 16-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 37: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 38: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 39: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 40: World Diabetes Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES

Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
With Diabetes Emerging as a Major Lifestyle Disease, Diabetes Diagnostics Market Poised for Growth in the US
Diabetes and Population Statistics in North America and Caribbean Region (2019, 2030 & 2045)
Diabetes Prevalence by Ethnicity
Aging Demographics: A Factor Driving Diabetes Prevalence
Population of 65+ Age Group (in Thousands) in the US for 2019 and 2030
North American Aging Population (in Thousands) by Age Group: 1975-2050
Diabetes Prevalence in the US: Percentage Share Breakdown of Number of Diabetics by Age Group
Rising Significance of Wearable and Non-Invasive Glucose Monitoring Devices
Regulatory Guidance for Glucose Meter Companies
Insulin Syringes Dominate the Insulin Delivery Devices Market
Emerging Grey Market for Testing Strips
Competition
Companies Focus on Research for Better Diabetes Diagnostics

CANADA

Rising Diabetes Incidence in Canada: Opportunity for Diabetes Diagnostics Market

JAPAN

Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
Aging Population Drives Diabetes Diagnostics Market

CHINA

Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
Increasing Diabetes Incidence Drives Market Growth
Lower Penetration Offers High Growth Potential

EUROPE

Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
Diabetes Diagnostics Market in Europe: A Promising Outlook
Diabetes and Population Statistics in Europe (2019, 2030 & 2045)
Reimbursement Scenario

FRANCE

Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)

GERMANY

Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)

ITALY

UNITED KINGDOM

Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
Market Overview
Diabetic Foot Ulcers in UK

SPAINRUSSIAREST OF EUROPE

ASIA-PACIFIC

Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
Asia-Pacific: Rising Diabetes Incidence Offers Significant Growth Opportunities
Diabetes and Population Statistics in South East Asia (2019 & 2045)
Diabetes and Population Statistics in Western Pacific (2019 & 2045)
Public and Private Sector Diabetes Care

AUSTRALIA

Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)

INDIA

Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
Expanding Diabetic Population Spurs Growth in the Indian Market
Blood Glucose Monitoring Market: An Overview
HbA1c Testing Continues to Gain Momentum
Glucose Meters Rely on Imported Technology

SOUTH KOREAREST OF ASIA-PACIFIC

LATIN AMERICA

Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
Rising Diabetes Cases Present Opportunities for Diabetes Diagnostics in Latin America
Diabetes and Population Statistics in South & Central America (2019 & 2045)

ARGENTINABRAZILMEXICOREST OF LATIN AMERICA

MIDDLE EAST

Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)

IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST

AFRICA

Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)

IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Abbott Laboratories, Inc.
B. Braun Melsungen AG
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Danaher Corporation
ACON Laboratories, Inc.
ARKRAY, Inc.
A. Menarini Diagnostics Srl
AgaMatrix, Inc.
BIONIME Corporation
Ascensia Diabetes Care Holdings AG
American Laboratory Products Company (ALPCO)
AmbiMedInc
Companion Medical, Inc.
Ciga Healthcare Ltd.

Table Information

Report Attribute	Details
No. of Pages	609
Published	March 2024
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 33.4 Billion
Forecasted Market Value ( USD ) by 2030	$ 59.4 Billion
Compound Annual Growth Rate	7.5%
Regions Covered	Global

PURCHASE OPTIONS

Single User License PDF

1 - 10 User License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5388EUR$5,600USD£4,559GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€10238EUR$10,640USD£8,661GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€16165EUR$16,800USD£13,676GBP

Key Insights:

Why You Should Buy This Report:

Key Questions Answered:

Report Features:

Select Competitors (Total 91 Featured):

MarketGlass Platform

Table of Contents

Companies Mentioned (Partial List)

Table Information

Related Topics

Related Reports

Digital Diabetes Management - Global Strategic Business Report

Diabetes Injection Pens - Global Strategic Business Report

Global Diabetes Diagnostics Market by Diabetes Type (Diabetes I, Diabetes II, Gestational Diabetes), Product (Biochips, Glucose Monitors, Kits), Diabetes Diagnostics Type, End-User - Forecast 2024-2030

Digital Diabetes Management Global Market Report 2024

Artificial Intelligence in Diabetes Management Global Market Report 2024